Daniel Cartwright

Chief Financial Officer

Professional Overview

Daniel Cartwright is an accomplished Chief Financial Officer with extensive experience in the pharmaceutical industry. He is known for his strategic financial leadership, driving operational excellence, and delivering sustainable growth for organizations.

Experience Summary

Current Role

As the Chief Financial Officer at TherapeuticsMD, Daniel is responsible for overseeing the company's financial operations, strategic planning, and risk management. He plays a crucial role in aligning financial strategies with the organization's overall business objectives, ensuring efficient resource allocation and profitability.

Under Daniel's financial stewardship, TherapeuticsMD has achieved significant milestones, including securing major funding rounds, navigating complex regulatory environments, and expanding the company's product portfolio. His keen analytical skills, coupled with a deep understanding of the pharmaceutical industry, have been instrumental in driving the company's financial performance and positioning it for long-term success.

Career Progression

Prior to joining TherapeuticsMD, Daniel held senior finance roles at several leading pharmaceutical companies, where he demonstrated a track record of driving operational improvements, optimizing financial processes, and implementing strategic initiatives. His experience spans various aspects of financial management, including budgeting, forecasting, treasury management, and investor relations.

Throughout his career, Daniel has been recognized for his ability to navigate complex financial landscapes, identify growth opportunities, and implement effective cost-saving measures. His contributions have been instrumental in enhancing the financial resilience and profitability of the organizations he has served.

Academic Background

Daniel holds a Master of Business Administration (MBA) from the University of Florida, where he specialized in Finance and Accounting. He also possesses a Bachelor of Science (B.S.) in Accounting from the University of Miami, graduating with honors.

Areas of Expertise

• Financial strategy and planning

• Operational optimization and cost management

• Regulatory compliance and risk mitigation

• Mergers, acquisitions, and integration

• Performance management and reporting

• Investor relations and capital markets

Professional Impact

Under Daniel's financial leadership, TherapeuticsMD has achieved several key milestones, including:

• Securing $150 million in Series C funding to fuel the company's product development and commercial expansion

• Streamlining financial processes and systems, resulting in a 20% reduction in operational costs

• Navigating the company's successful FDA approval and commercial launch of a groundbreaking women's health product

• Expanding the company's global footprint, establishing strategic partnerships and licensing agreements in international markets

Conclusion

With his exceptional financial acumen, strategic vision, and industry expertise, Daniel Cartwright is poised to continue driving the growth and success of TherapeuticsMD. His commitment to operational excellence, financial discipline, and collaborative leadership style make him a valuable asset to the organization and a respected leader in the pharmaceutical industry.